Mechanism of cell damage and repair in acute lung injury

急性肺损伤的细胞损伤与修复机制

基本信息

  • 批准号:
    16390457
  • 负责人:
  • 金额:
    $ 8.53万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2007
  • 项目状态:
    已结题

项目摘要

The first study was performed to examine the putative role of high-mobility group box (HMGB) protein in the pathogenesis of acute lung injury. Observations were made 1) in 21 septic patients with acute lung injury and 15 patients with normal lung function, and 2) in a mouse model, 24 h after intratracheal instillation of lipopolysaccharide. The concentrations of HMGB 1 were increased in plasma and lung epithelial lining fluid of patients with acute lung injury and mice instilled with lipopolysaccharide. Lipopolysaccharide-induced acute lung injury was mitigated by anti-HMGB1 antibody. Although this protein was not detected in the plasma of control humans or mice, the concentrations of HMGB 1 in lung epithelial lining fluid or in bronchoalveolar lavage fluid were unexpectedly high. The nuclear expression of HMGB 1 was apparent in epithelial cells surrounding terminal bronchioles in normal mice, while its nuclear and cytoplasmic expression was observed in alveolar macrophages in lipopoly … More saccharide-instilled mice. Lung instillation of HMGB2 did not cause as much inflammation as HMGB 1. Extracellular HMGB 1 may play a key role in the pathogenesis of clinical and experimental acute lung injury. However, its expression in normal airways is noteworthy, and suggests that it also plays a physiologic role in the lung. And the second study was about Fas/FasL system. Alveolar epithelial cell death plays a crucial role in the progression of acute lung injury. We have demonstrated up-regulation of Fas expression on alveolar epithelial cells, and soluble Fas ligand secretion from inflammatory cells upon acute lung injury. Here we show that the lipopolysaccharide-stimulated human monocyte cell line THP-1 releases Fas ligand, and that conditioned medium from lipopolysaccharide-stimulated THP-1 cells induces apoptosis of the human pulmonary adenocarcinoma cell line A549. Activation of caspase-3 and -8 is associated with the apoptosis. Gene targeting on Fas in A549 cells by specific small interfering RNA impairs apoptosis induced by conditioned medium from activated THP-1, while that on Fas ligand in THP-1 cells impairs the apoptosis-inducing activity of the conditioned medium produced by lipopolysaccharide-stimulated cells. These results suggest that Fas ligand released by monocytes causes alveolar epithelial cell death through a Fas-dependent apoptotic mechanism in the development of acute lung injury. Less
在21例肺部损伤患者中进行了第一项研究,以高运动组盒(HMGB)蛋白在急性肺的发病机理中的推定作用。小鼠模型,急性肺和小鼠的静脉内液体含量为24小时。流体或支气管肺泡灌洗液中的核表达是在正常遗迹中明显的HMGB2的滴注不如HMGB 1。细胞外HMGB 1可能在临床轴心急性肺损伤的发病机理中起着AKEY的作用。在进展的肺部损伤中,我们在肺泡上皮上表现出FAS的上调,并在急性肺部损伤中向炎症细胞提供了FAS。 1释放FAS配体,从脂多糖刺激的THP -1细胞中诱导人肺rcinoma rcinoma rcinoma cyl a549的凋亡。细胞会损害损害脂多糖刺激的细胞产生的分离培养基的凋亡型的凋亡,这些结果表明,单核细胞释放的FAS配体肺泡细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞池细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞细胞</s> </s> </s> </s>

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
High mobility group protein (HMGB1) as a possible mediator of acute exacerbation in idiopathic pulmonary fibrosis
高迁移率族蛋白(HMGB1)作为特发性肺纤维化急性加重的可能介质
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ebina;M.;Kimura;Y.;Shibata;N.;Konishi;K.;Ishizaka;A.;Hashimoto;S.;MaruyamaI;Nukiwa;T
  • 通讯作者:
    T
Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid
  • DOI:
    10.1111/j.1440-1843.2007.01208.x
  • 发表时间:
    2008-03-01
  • 期刊:
  • 影响因子:
    6.9
  • 作者:
    Kikuchi, Eiki;Yamazaki, Koichi;Nishimura, Masaharu
  • 通讯作者:
    Nishimura, Masaharu
Measurement of neutrophil elastase activity in ARDS patients treated with neutrophil elastase inhibitor
中性粒细胞弹性蛋白酶抑制剂治疗的 ARDS 患者中性粒细胞弹性蛋白酶活性的测定
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hashimoto;S.;Okayama;Y.;Shime;N.;Amaya;F.;Ishizaka;A
  • 通讯作者:
    A
Endothelin-1 levels of serum and epithelial lining fluid in ALI/ARDS
ALI/ARDS 患者血清和上皮衬里液的内皮素-1 水平
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nakano;Y.;S.;Tasaka;Hashimoto;S.;Ogawa;Y.;Kurihara;A.;Saito;F.;Yamada;W.;Shimizu;M.;Koh;H.;Nakamura;M.;Hasegawa;N.;Fujishima;S.;Ishizaka;A
  • 通讯作者:
    A
Effects of controlled perioperative antimicrobial prophylaxis on infectious outcomes in pediatric cardiac surgery
  • DOI:
    10.1097/01.ccm.0000269027.50834.fe
  • 发表时间:
    2007-07-01
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Kato, Yuko;Shime, Nobuaki;Fujita, Naohisa
  • 通讯作者:
    Fujita, Naohisa
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HASHIMOTO Satoru其他文献

HASHIMOTO Satoru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HASHIMOTO Satoru', 18)}}的其他基金

Abnormal transcriptional regulation in Cockayne syndrome and its effect on neuronal differentiation
Cockayne 综合征转录调控异常及其对神经元分化的影响
  • 批准号:
    15K06758
  • 财政年份:
    2015
  • 资助金额:
    $ 8.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The analyses of price differential in Japanese natural gas industry
日本天然气行业价格差异分析
  • 批准号:
    24830032
  • 财政年份:
    2012
  • 资助金额:
    $ 8.53万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Biomakers associated with ventilator associated lung injury
与呼吸机相关肺损伤相关的生物制造商
  • 批准号:
    20390460
  • 财政年份:
    2008
  • 资助金额:
    $ 8.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Apoptosis and inflammatory cell in the pathogenesis of acute lung injury
急性肺损伤发病机制中的凋亡和炎症细胞
  • 批准号:
    13470326
  • 财政年份:
    2001
  • 资助金额:
    $ 8.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
APOPTOSIS IN ACUTE LUNG INJURY
急性肺损伤中的细胞凋亡
  • 批准号:
    10470322
  • 财政年份:
    1998
  • 资助金额:
    $ 8.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Inter-cellular signal transduction by alveolar macrophages in acute lung injury
急性肺损伤中肺泡巨噬细胞的细胞间信号转导
  • 批准号:
    07407045
  • 财政年份:
    1995
  • 资助金额:
    $ 8.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)

相似国自然基金

NEAT1促进HMGB1胞外释放的分子机制及其在脓毒症炎症反应中的作用研究
  • 批准号:
    82372515
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
脑源性微囊泡通过HMGB1途径加重颅脑损伤后肺损伤的机制研究
  • 批准号:
    82371386
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
脂肪细胞分泌乳酸化HMGB1蛋白调控脂肪-巨噬细胞交叉对话诱导腹主动脉瘤形成
  • 批准号:
    82300548
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
LCN2介导HMGB1/GPX4调控VICs铁死亡促进CKD心瓣膜钙化的机制研究
  • 批准号:
    82370742
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于HMGB1/TLR4-小胶质细胞极化-重塑周围神经网络研究乳香-没药“化瘀通络”治疗神经病理性疼痛的作用及机制
  • 批准号:
    82304947
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

HMGB1とハプトグロビンによる敗血症の進展に関わるメカニズムの解明
阐明 HMGB1 和触珠蛋白导致脓毒症发生的机制
  • 批准号:
    24K19461
  • 财政年份:
    2024
  • 资助金额:
    $ 8.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
巨核球・血小板系由来HMGB1の各種難治性疼痛への関与
巨核细胞/血小板来源的HMGB1参与各种顽固性疼痛
  • 批准号:
    24K09838
  • 财政年份:
    2024
  • 资助金额:
    $ 8.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
全身性エリテマトーデスにおけるHMGB1を標的とした新規治療薬の開発
开发针对系统性红斑狼疮的HMGB1新治疗药物
  • 批准号:
    24K19235
  • 财政年份:
    2024
  • 资助金额:
    $ 8.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
非平衡大気圧プラズマを用いた還元型HMGB1による新しい創傷治療薬の開発
利用非平衡大气压等离子体还原HMGB1开发新型伤口治疗药物
  • 批准号:
    23K24509
  • 财政年份:
    2024
  • 资助金额:
    $ 8.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
非平衡大気圧プラズマとHMGB1 による虚血性遷延性潰瘍に対する新規治療薬の開発
利用非平衡大气压等离子体和HMGB1开发缺血性持续性溃疡新治疗剂
  • 批准号:
    24K12851
  • 财政年份:
    2024
  • 资助金额:
    $ 8.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了